Suppression of phagocytosis and chemotaxis by cell wall components of Staphylococcus aureus. 1981

D M Musher, and H A Verbrugh, and J Verhoef

The ability of S. aureus to resist phagocytosis by polymorphonuclear leukocytes (PMN) is thought to be an important virulence factor for this microorganism. We have studied the effect of 3 major cell wall components of S. aureus, peptidoglycan, protein A, and teichoic acid, on PMN function. Phagocytosis and chemotaxis were both inhibited by prior incubation of PMN with peptidoglycan. This effect was dose- and time-related; incubation with as little as 2.5 micrograms/ml for 30 min produced a discernible suppressive effect. Suppression of PMN function was independent of the presence of human serum but was abolished by rabbit antiserum to peptidoglycan. Addition of peptidoglycan to PMN stimulated a prolonged chemiluminescence response that was greater when the peptidoglycan was first incubated in normal serum, perhaps reflection opsonization of this particulate material. Although protein A also suppressed phagocytic and chemotactic capabilities of PMN, this effect was observed only in the presence of serum and was eliminated by absorbing Ig. Centrifugation of the serum + protein A mixture showed that the suppressive effect was contained in the precipitated sediment. Complexes of Ig alone were not suppressive. Teichoic acid in concentrations less than or equal to 100 micrograms/ml had no adverse effect on PMN function. These studies describe ways in which peptidoglycan and protein A may interfere with phagocytosis and chemotaxis of human PMN, thus giving evidence for the role of these cell wall components as virulence factors.

UI MeSH Term Description Entries
D007165 Immunosuppression Therapy Deliberate prevention or diminution of the host's immune response. It may be nonspecific as in the administration of immunosuppressive agents (drugs or radiation) or by lymphocyte depletion or may be specific as in desensitization or the simultaneous administration of antigen and immunosuppressive drugs. Antirejection Therapy,Immunosuppression,Immunosuppressive Therapy,Anti-Rejection Therapy,Therapy, Anti-Rejection,Therapy, Antirejection,Anti Rejection Therapy,Anti-Rejection Therapies,Antirejection Therapies,Immunosuppression Therapies,Immunosuppressions,Immunosuppressive Therapies,Therapies, Immunosuppression,Therapies, Immunosuppressive,Therapy, Immunosuppression,Therapy, Immunosuppressive
D008163 Luminescent Measurements Techniques used for determining the values of photometric parameters of light resulting from LUMINESCENCE. Bioluminescence Measurements,Bioluminescent Assays,Bioluminescent Measurements,Chemiluminescence Measurements,Chemiluminescent Assays,Chemiluminescent Measurements,Chemoluminescence Measurements,Luminescence Measurements,Luminescent Assays,Luminescent Techniques,Phosphorescence Measurements,Phosphorescent Assays,Phosphorescent Measurements,Assay, Bioluminescent,Assay, Chemiluminescent,Assay, Luminescent,Assay, Phosphorescent,Assays, Bioluminescent,Assays, Chemiluminescent,Assays, Luminescent,Assays, Phosphorescent,Bioluminescence Measurement,Bioluminescent Assay,Bioluminescent Measurement,Chemiluminescence Measurement,Chemiluminescent Assay,Chemiluminescent Measurement,Chemoluminescence Measurement,Luminescence Measurement,Luminescent Assay,Luminescent Measurement,Luminescent Technique,Measurement, Bioluminescence,Measurement, Bioluminescent,Measurement, Chemiluminescence,Measurement, Chemiluminescent,Measurement, Chemoluminescence,Measurement, Luminescence,Measurement, Luminescent,Measurement, Phosphorescence,Measurement, Phosphorescent,Measurements, Bioluminescence,Measurements, Bioluminescent,Measurements, Chemiluminescence,Measurements, Chemiluminescent,Measurements, Chemoluminescence,Measurements, Luminescence,Measurements, Luminescent,Measurements, Phosphorescence,Measurements, Phosphorescent,Phosphorescence Measurement,Phosphorescent Assay,Phosphorescent Measurement,Technique, Luminescent,Techniques, Luminescent
D009504 Neutrophils Granular leukocytes having a nucleus with three to five lobes connected by slender threads of chromatin, and cytoplasm containing fine inconspicuous granules and stainable by neutral dyes. LE Cells,Leukocytes, Polymorphonuclear,Polymorphonuclear Leukocytes,Polymorphonuclear Neutrophils,Neutrophil Band Cells,Band Cell, Neutrophil,Cell, LE,LE Cell,Leukocyte, Polymorphonuclear,Neutrophil,Neutrophil Band Cell,Neutrophil, Polymorphonuclear,Polymorphonuclear Leukocyte,Polymorphonuclear Neutrophil
D010457 Peptidoglycan A structural polymer of the bacterial cell envelope consisting of sugars and amino acids which is responsible for both shape determination and cellular integrity under osmotic stress in virtually all bacteria. Murein,Pseudomurein
D010587 Phagocytosis The engulfing and degradation of microorganisms; other cells that are dead, dying, or pathogenic; and foreign particles by phagocytic cells (PHAGOCYTES). Phagocytoses
D011817 Rabbits A burrowing plant-eating mammal with hind limbs that are longer than its fore limbs. It belongs to the family Leporidae of the order Lagomorpha, and in contrast to hares, possesses 22 instead of 24 pairs of chromosomes. Belgian Hare,New Zealand Rabbit,New Zealand Rabbits,New Zealand White Rabbit,Rabbit,Rabbit, Domestic,Chinchilla Rabbits,NZW Rabbits,New Zealand White Rabbits,Oryctolagus cuniculus,Chinchilla Rabbit,Domestic Rabbit,Domestic Rabbits,Hare, Belgian,NZW Rabbit,Rabbit, Chinchilla,Rabbit, NZW,Rabbit, New Zealand,Rabbits, Chinchilla,Rabbits, Domestic,Rabbits, NZW,Rabbits, New Zealand,Zealand Rabbit, New,Zealand Rabbits, New,cuniculus, Oryctolagus
D002473 Cell Wall The outermost layer of a cell in most PLANTS; BACTERIA; FUNGI; and ALGAE. The cell wall is usually a rigid structure that lies external to the CELL MEMBRANE, and provides a protective barrier against physical or chemical agents. Cell Walls,Wall, Cell,Walls, Cell
D002634 Chemotaxis, Leukocyte The movement of leukocytes in response to a chemical concentration gradient or to products formed in an immunologic reaction. Leukotaxis,Leukocyte Chemotaxis
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia

Related Publications

D M Musher, and H A Verbrugh, and J Verhoef
January 2003, Antibiotiki i khimioterapiia = Antibiotics and chemoterapy [sic],
D M Musher, and H A Verbrugh, and J Verhoef
December 2020, Drug discovery today. Technologies,
D M Musher, and H A Verbrugh, and J Verhoef
September 2012, Seikagaku. The Journal of Japanese Biochemical Society,
D M Musher, and H A Verbrugh, and J Verhoef
January 2015, Biological & pharmaceutical bulletin,
D M Musher, and H A Verbrugh, and J Verhoef
January 2004, Antibiotiki i khimioterapiia = Antibiotics and chemoterapy [sic],
D M Musher, and H A Verbrugh, and J Verhoef
April 1987, Danish medical bulletin,
D M Musher, and H A Verbrugh, and J Verhoef
October 1979, Infection and immunity,
D M Musher, and H A Verbrugh, and J Verhoef
March 1982, Archives of microbiology,
D M Musher, and H A Verbrugh, and J Verhoef
January 2023, Frontiers in aging,
D M Musher, and H A Verbrugh, and J Verhoef
April 1981, The veterinary quarterly,
Copied contents to your clipboard!